3.8 Review

Genetic causes of dilated cardiomyopathy

Journal

PROGRESS IN PEDIATRIC CARDIOLOGY
Volume 37, Issue 1-2, Pages 13-18

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ppedcard.2014.10.003

Keywords

Dilated cardiomyopathy; Gene; Prognosis; Screening; Pediatrics; Heart failure

Funding

  1. NIH [UL1 RR025780, UL1 TR001082, N01-HV-48194, R01 HL69071, R01 HL 116906, K23 JL067915, R01HL109209]
  2. CRTrieste Foundation
  3. GENERALI Foundation

Ask authors/readers for more resources

Dilated cardiomyopathy is a disease of the myocardium characterized by left ventricular dilatation and/or dysfunction, affecting both adult and pediatric populations. Almost half of cases are genetically determined with an autosomal pattern of inheritance. Up to 40 genes have been identified affecting proteins of a wide variety of cellular structures such as the sarcomere, the nuclear envelope, the cytoskeleton, the sarcolemma and the intercellular junction. Novel gene mutations have been recently identified thanks to advances in next-generation sequencing technologies. Genetic screening is an essential tool for early diagnosis, risk assessment, prognostic stratification and, possibly, adoption of primary preventive measures in affected patients and their asymptomatic relatives. The purpose of this article is to review the genetic basis of DCM, the known genotype-phenotype correlations, the role of current genetic sequencing techniques in the discovery of novel pathogenic gene mutations and new therapeutic perspectives. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available